Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department

被引：37
作者：
Brown, Michael D.
Burton, John H.
Nazarian, Devorah J.
Promes, Susan B.
机构：
来源：
ANNALS OF EMERGENCY MEDICINE | 2015年 / 66卷 / 03期
关键词：
SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; COMPUTED-TOMOGRAPHY SCORE; COOPERATIVE ACUTE STROKE; SHARED DECISION-MAKING; MIDDLE CEREBRAL-ARTERY; THROMBOLYTIC THERAPY; INTRACRANIAL HEMORRHAGE; ENDOVASCULAR TREATMENT; RT-PA; SAFE IMPLEMENTATION;
D O I：
10.1016/j.annemergmed.2015.06.031
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
This clinical policy from the American College of Emergency Physicians is the revision of a clinical policy approved in 2012 addressing critical questions in the evaluation and management of patients with acute ischemic stroke.(1) A writing subcommittee conducted a systematic review of the literature to derive evidence-based recommendations to answer the following clinical questions: (1) Is intravenous tissue plasminogen activator safe and effective for patients with acute ischemic stroke if given within 3 hours of symptom onset? (2) Is intravenous tissue plasminogen activator safe and effective for patients with acute ischemic stroke treated between 3 to 4.5 hours after symptom onset? Evidence was graded and recommendations were made according to the strength of the available data.
引用
收藏
页码：322 / 333
页数：12
相关论文
共 99 条
  • [1] Outcomes of Intravenous Thrombolysis After Dissemination of the Stroke Code and Designation of New Referral Hospitals in Catalonia The Catalan Stroke Code and Thrombolysis (Cat-SCT) Monitored Study
    Abilleira, Sonia
    Davalos, Antoni
    Chamorro, Angel
    Alvarez-Sabin, Jose
    Ribera, Aida
    Gallofre, Miquel
    [J]. STROKE, 2011, 42 (07) : 2001 - 2006
  • [2] Results of Intravenous Thrombolysis Within 4.5 to 6 Hours and Updated Results Within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR) An Observational Study
    Ahmed, Niaz
    Kellert, Lars
    Lees, Kennedy R.
    Mikulik, Robert
    Tatlisumak, Turgut
    Toni, Danilo
    [J]. JAMA NEUROLOGY, 2013, 70 (07) : 837 - 844
  • [3] Predictors of In-hospital Mortality and the Risk of Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
    Al-Khaled, Mohamed
    Matthis, Christine
    Eggers, Juergen
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (01) : 7 - 11
  • [4] Alias Mathew, 2011, Conn Med, V75, P531
  • [5] American College of Emergency Physicians, 2013, Ann Emerg Med, V61, P225, DOI 10.1016/j.annemergmed.2012.11.005
  • [6] [Anonymous], 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]
  • [7] Antoncic I, 2011, COLLEGIUM ANTROPOL, V35, P483
  • [8] NIHSS-time score easily predicts outcomes in rt-PA patients: The SAMURAI rt-PA registry
    Aoki, Junya
    Kimura, Kazumi
    Koga, Masatoshi
    Kario, Kazuomi
    Nakagawara, Jyoji
    Furui, Eisuke
    Shiokawa, Yoshiaki
    Hasegawa, Yasuhiro
    Okuda, Satoshi
    Yamagami, Hiroshi
    Okada, Yasushi
    Shibazaki, Kensaku
    Sakamoto, Yuki
    Toyoda, Kazunori
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 327 (1-2) : 6 - 11
  • [9] Outcomes validity and reliability of the modified Rankin scale: Implications for stroke clinical trials - A literature review and synthesis
    Banks, Jamie L.
    Marotta, Charles A.
    [J]. STROKE, 2007, 38 (03) : 1091 - 1096
  • [10] A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
    Berkhemer, O. A.
    Fransen, P. S. S.
    Beumer, D.
    van den Berg, L. A.
    Lingsma, H. F.
    Yoo, A. J.
    Schonewille, W. J.
    Vos, J. A.
    Nederkoorn, P. J.
    Wermer, M. J. H.
    van Walderveen, M. A. A.
    Staals, J.
    Hofmeijer, J.
    van Oostayen, J. A.
    Nijeholt, G. J. Lycklama A.
    Boiten, J.
    Brouwer, P. A.
    Emmer, B. J.
    de Bruijn, S. F.
    van Dijk, L. C.
    Kappelle, L. J.
    Lo, R. H.
    Van Dijk, E. J.
    de Vries, J.
    de Kort, P. L. M.
    van Rooij, W. J. J.
    van den Berg, J. S. P.
    van Hasselt, B. A. A. M.
    Aerden, L. A. M.
    Dallinga, R. J.
    Visser, M. C.
    Bot, J. C. J.
    Vroomen, P. C.
    Eshghi, O.
    Schreuder, T. H. C. M. L.
    Heijboer, R. J. J.
    Keizer, K.
    Tielbeek, A. V.
    den Hertog, H. M.
    Gerrits, D. G.
    van den Berg-Vos, R. M.
    Karas, G. B.
    Steyerberg, E. W.
    Flach, H. Z.
    Marquering, H. A.
    Sprengers, M. E. S.
    Jenniskens, S. F. M.
    Beenen, L. F. M.
    van den Berg, R.
    Koudstaal, P. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (01) : 11 - 20
12345678910